JAMA

Lower Gastrointestinal Hemorrhage

This JAMA Clinical Guidelines Synopsis summarizes the 2023 American College of Gastroenterology guidelines on management of patients with acute lower gastrointestinal bleeding.

Arteriovenous Access for Hemodialysis – A Review

Importance  Hemodialysis requires reliable vascular access to the patient’s blood circulation, such as an arteriovenous access in the form of an autogenous arteriovenous fistula or nonautogenous arteriovenous graft. This Review addresses key issues associated with the construction and maintenance of hemodialysis…

Primary Care Interventions to Prevent Child Maltreatment – Evidence Report and Systematic Review for the US Preventive Services Task Force

Importance  Child maltreatment is associated with serious negative physical, psychological, and behavioral consequences. Objective  To review the evidence on primary care–feasible or referable interventions to prevent child maltreatment to inform the US Preventive Services Task Force. Data Sources  PubMed, Cochrane Library, and trial…

ADHD Pharmacotherapy and Mortality in Individuals With ADHD

Importance  Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risks of adverse health outcomes including premature death, but it is unclear whether ADHD pharmacotherapy influences the mortality risk. Objective  To investigate whether initiation of ADHD pharmacotherapy was associated with reduced mortality risk in…

Allergic Rhinitis – A Review

Importance  Allergic rhinitis affects an estimated 15% of the US population (approximately 50 million individuals) and is associated with the presence of asthma, eczema, chronic or recurrent sinusitis, cough, and both tension and migraine headaches. Observations  Allergic rhinitis occurs when disruption of…

Infectious Diseases in a Changing Climate

This JAMA Insights in the Climate Change and Health series discusses the importance of clinicians having awareness of changes in the geographic range, seasonality, and intensity of transmission of infectious diseases to help them diagnose, treat, and prevent these diseases.

Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis

This article summarizes a 2022 clinical practice guideline on the use of disease-modifying antirheumatic drugs (DMARDs) for adults with rheumatoid arthritis from the European League Against Rheumatism (EULAR).